tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jazz Pharmaceuticals sees FY25 adjusted EPS $22.50-$24.00, consensus $22.03

Sees FY25 revenue $4.15B-$4.4B, consensus $4.34B.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1